Waqas Ullah

Former Cardiology Fellow @TJUHospital. IC Fellow @UMass

[Neel Patel, MD @NPatelMD]

Excited to share our recently published network meta analysis comparing revascularization strategies for ACS patients with multi vessel disease. @MyJSCAI #CardioTwitter #ACS #PCI
@chadialraies @timir_paul @DryasarsattarMD @KhHarmouch @dr_hamza_md @vakasullah @PrakashUpretiMD

[Waqas Ullah @vakasullah]

New insights from our network meta-analysis! Findings suggest a potential update in guidelines for de-escalation therapies in post-ACI patients. Thanks @adnanalkhouli @DocSavageTJU @fischman_david @SVRaoMD @SalmanZahidMD @smitha_narayana @MaryamM49508311

[JAHA @JAHA_AHA]

In patients with ACS undergoing PCI, aspirin+clopidogrel after a short period of high potency DAPT can mitigate the risk of major bleeding while preserving the ischemic benefits. #AHAJournals @vakasullah @TJHeartFellows @adnanalkhouli @UMassCardio https://t.co/Bzj9ylYJCg

[Mamas A. Mamas @mmamas1973]

Our work led by @amstcro showing that trial participation in pts withACS associated with ⬇️CV readmissions
With @RodrigoBagur @DrSaritaRao2 @DrSarahjZaman @vakasullah @Ayman_Elbadawi_ @islamelgendy83 @ZSiudak

[MyJSCAI @MyJSCAI]

🆕📚Outcomes of #TAVR in pts across various hemodynamic subtypes of severe AS. #TAVI

Read now ➡️https://t.co/7Abw8bDdq7

@vakasullah @AVishnevsky_MD @adnanalkhouli @KhawarSana @MaryamM49508311 @SalmanZahidMD

[Waqas Ullah @vakasullah]

Check out our 📝 in @MyJSCAI on outcomes of TAVI in hemodynamic subtypes of AS. @TJHeartFellows. Thanks @AVishnevsky_MD @adnanalkhouli @KhawarSana @MaryamM49508311 @SalmanZahidMD Link: https://t.co/2j7QpIoE0G

[Waqas Ullah @vakasullah]

With an excellent editorial summary by @PShoureshi. Link: https://t.co/po1oItOARU.

[Waqas Ullah @vakasullah]

Our ✍️ in @JACCJournals shows poor discriminatory accuracy of CHADS-VASc score in AF with cancer and ⬆️ bleeding risk than stroke. @mmamas1973 @RodrigoBagur @sunlouise1 @fischman_david @FrischMd @amstcro @Matt_DiMeglio @TJHeartFellows. Link: https://t.co/II8Gn7ZqZI

[Joey Junarta @JunartaMD]

Excited to share our network meta-analysis comparing vHPSD, HPSD, and LPLD radiofrequency ablation settings for AF! @FrischMd @SDikdan @vakasullah @TJHeartFellows (https://t.co/Ea3SKEFZXB) #EPeeps #CardioTwitter

[Michael Savage @DocSavageTJU]

@MansoorBWH presenting our meta-analysis on #DES in #SVG @vakasullah @mmamas1973 @SVRaoMD @DLBHATTMD @DrMarthaGulati @djc795 @fjpinto1960 @Pooh_Velagapudi @aymanka @mirvatalasnag @fischman_david #AHA23 #CardioTwitter DES is no longer “love in vein” ➡️ https://t.co/aFpjdYzpOu

[Yevgeniy Brailovsky DO MSc FACC @YevgeniyBr]

Please see our accompanying editorial where we highlight important innovations in catheter-based therapies of PE and suggest future directions for outcome measures in interventional PE trials https://t.co/CwPkVzruie @vakasullah @PERTConsortium

[David L. Fischman @fischman_david]

Catching up with @TJUHospital IC fellows past, present and future @crfheart #TCT2023 @Brian_R_Osler @adityamunshi @vakasullah @mirzozodaMD_MBA @pritixyz @ramz9012 @TJHeartFellows @DocSavageTJU @DavidWienerMD #CardioTwitter #ACCFIT

[Mahboob Alam @BaylorCardio]

@vakasullah @DryasarsattarMD It was nice to catch up with two truly aspirational future interventional stars and highly prolific clinical-investigators! Keep up the strong work and wish you all the best in your exciting careers! @SCAI @SCAI_Prez @ACCinTouch @srf_aku @txchapteracc

[Waqas Ullah @vakasullah]

Read our editorial in @JACCJournals on the great work done by @afshin_ehsan and colleagues on heart failure readmissions after cardiac surgeries @YevgeniyBr @IRajapreyar @TJHeartFellows. Editorial: https://t.co/5pXIONxQ3i. Original Article: https://t.co/uaLv4SvOwq

[MyJSCAI @MyJSCAI]

📖Three Time Loser or Third Time's the Charm? #PCI of Recurrent Restenosis After Overlapped #DES. After a 3rd PCI for #ISR, 3 / 4 patients had a subsequent TVR or other MACE within 3 years. #CardioTwitter

➡️https://t.co/DV4sERser8

[Yevgeniy Brailovsky DO MSc FACC @YevgeniyBr]

Thank you 🙏 @JGrapsa @JACCJournals for giving us a platform. Congratulations @max_ruge_md for leading the effort. @IRajapreyar @TJHeartFellows @JeffIMchiefs @ic_cooper @fischman_david @DocSavageTJU @DavidWienerMD @AHajduczok @EstefaniaOS @TJUHospital @CooperCVFellows

[Joey Junarta @JunartaMD]

Our study suggests a lower risk of all-cause mortality in patients with cardiac amyloidosis with AS who underwent TAVR vs. medical therapy alone. @YevgeniyBr @IRajapreyar @SiddiqiUmer @vakasullah @TJHeartFellows #CardioTwitter

https://t.co/KeQdt11nTR

[Waqas Ullah @vakasullah]

Our 📝 in @ESC_Journals @ehjopen shows a high risk of mortality, procedural complications and resource utilization with AF ablation in HF. @TJHeartFellows @AHajduczok @KirpalKocharMD Thanks @IRajapreyar @YevgeniyBr @FrischMd. Link: https://t.co/pwT0zpVKkD

[Waqas Ullah @vakasullah]

Followed by a great editorial by @Pooh_Velagapudi link: https://t.co/VhAip8mF9S

[Waqas Ullah @vakasullah]

Our 📝 in @JACCJournals shows a high risk of adverse events with TAVI in conditions excluded by clinical trials (except BAV, PUD and leukopenia). Thanks @DLBHATTMD @PinakShahMD @mmamas1973 @DocSavageTJU @ErinMichos @fischman_david @TJHeartFellows link: https://t.co/ln520NN80y

[Waqas Ullah @vakasullah]

Our 📝 in @JACCJournals showing ⬇️ or🟰MACE and mortality in pts undergoing TAVI compared with SAVR in most solid cancers except colorectal. @fischman_david @DocSavageTJU @chadialraies @DrNickTJU @AVishnevsky_MD @mmamas1973 @arnavkumar Link: https://t.co/TVEXPc9hIb